A carregar...
The metabolic regulator ERRα, a downstream target of HER2/IGF-1, as a therapeutic target in breast cancer
A genomic signature designed to assess the activity of the estrogen-related receptor alpha (ERRα) was used to profile more than eight hundred breast tumors, revealing a shorter disease-free survival in patients with tumors exhibiting elevated receptor activity. Importantly, this signature also predi...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3199323/ https://ncbi.nlm.nih.gov/pubmed/22014575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2011.08.023 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|